TrialAnnals of the rheumatic diseases2023

Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis.

Daniel H Solomon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.